Broadcom: The Dual Moat Is Still Undervalued

Broadcom’s AI semiconductor revenue is guided to $10.7B in Q2 FY26, up 140% YoY, with a long-term target of $100B by FY27. The article highlights durable growth in custom AI chips and VMware’s shift to a high-margin recurring software engine, supporting strong earnings compounding and resilient cash flow. The message is decisively positive for Broadcom’s fundamentals and AI monetization trajectory.

Analysis

The market is still pricing Broadcom like a good semis compounder, but the setup is closer to a two-engine cash machine with asymmetric reinvestment optionality. Custom silicon should keep taking share because hyperscalers increasingly care more about total cost per inference than merchant-chip purity, and that shifts bargaining power toward the design partner with the deepest software and networking stack. The second-order winner is the ecosystem around AI buildouts that depends on specialized packaging, HBM, and high-speed interconnect, while the obvious loser is any merchant AI accelerator exposed to a price/performance race and less sticky customer relationships.

The more underappreciated piece is VMware. If Broadcom can convert that base into a high-margin control layer for enterprise AI deployment, it creates a recurring distribution channel that lowers CAC for AI software and infrastructure attach rates. That makes the earnings durability better than a single-product chip story, and it also means any slowdown in semicap orders may be partially offset by software mix, which is why downside should be shallower than peers with pure hardware exposure.

Near term, the main risk is not demand collapse but customer concentration and execution: a handful of hyperscalers can defer or redesign programs if Broadcom slips on power, yield, or time-to-ramp. Over the next 3-6 months, the stock can overshoot on guidance momentum; over 12-24 months, the bigger issue is whether competing ASIC programs and in-house silicon eventually cap the margin mix. The contrarian point is that consensus may be underestimating how much of the upside is already a reinvestment story rather than a valuation rerate story, so the best returns may come from relative rather than outright exposure.

Key Decisions for Investors

• Maintain a core long AVGO position, but size it as a quality compounder rather than a high-beta AI trade; best risk/reward is on 6-12 month horizon where software mix can cushion any semis digestion.
• Add AVGO on pullbacks after any post-print compression of 8-12%, using weakness to build exposure rather than chasing strength; the key risk is hyperscaler program deferral, not end-demand destruction.
• Pair trade: long AVGO / short a basket of merchant AI accelerator names over the next 3-6 months to express the view that custom silicon + software integration wins the next leg of AI capex.
• For options, consider selling downside puts or put spreads 2-4 months out on AVGO if implied vol spikes; the thesis is that recurring software cash flow makes left-tail risk less severe than headline AI exposure suggests.
• Monitor hyperscaler capex commentary and VMware retention/attach metrics as the primary catalyst set; if either weakens for two consecutive quarters, reduce exposure materially because the multiple support becomes harder to defend.